The benefits of blood-based biopsies with OncoBEAM™

Patients wait 14-77 days for tissue biopsy results,1 often defaulting to chemotherapy instead of receiving the benefit of targeted therapy matched to their tumor’s molecular profile. Highly-sensitive, blood-based biopsies with OncoBEAM™ provide results in 5-7 days, minimizing treatment delays.

The benefits of blood-based biopsies with OncoBEAM™

Patients wait 14-77 days for tissue biopsy results,1 often defaulting to chemotherapy instead of receiving the benefit of targeted therapy matched to their tumor’s molecular profile. Highly-sensitive, blood-based biopsies with OncoBEAM™ provide results in 5-7 days, minimizing treatment delays.

OncoBEAM™ provides test results in 5–7 days

Clinic Visit Blood DrawClinic Visit Blood Draw

OncoBEAM™ Test RunOncoBEAM™ Test Run

Results ReportedResults Reported

For healthcare providers

Clinically actionable results from a simple blood draw

How much confidence can you put in results from a month-old tissue biopsy that may not represent a tumor’s overall status? OncoBEAM™ liquid biopsy assays are minimally invasive, highly sensitive and can overcome tumor molecular heterogeneity to deliver rapid results,2 helping you make critical decisions quickly.

Explore OncoBEAM™ liquid biopsy testing for your patients:

For patients

Maximum accuracy. Minimally invasive.

Tissue biopsies can be risky and inadequate. Sometimes, a sample doesn’t provide a full picture or more tests may need to be performed. That’s when patients face having to undergo repeat procedures. Blood-based biopsies with OncoBEAM™ require only a simple blood draw and there is plenty of sample.

Get a real-time snapshot of your patient's tumor mutation status

What is BEAMing technology?

Discover the OncoBEAM™ digital PCR advantage

Request more information

Get answers to your questions about OncoBEAM™

About Sysmex Inostics

Learn more about the makers of OncoBEAM™

References:

  1. Schwaederle, et al. Oncologist. 2014 Jun;19(6):631-6.
  2. Diaz, L. A. & Bardelli, A. Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol. 32, 579–586 (2014).